NEUROONE MEDICAL TECHNOLOGIE (NMTC) Stock Analyst Ratings
NASDAQ:NMTC - Nasdaq - US64130M2098 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 86% to NMTC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.48. This target is 147.74% above the current price.
NMTC was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about NMTC.
In the last month the buy percentage rose by 43 points. So the trust of analysts is improving.
NMTC was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-05 | Ladenburg Thalmann | Initiate | Buy |
| 2023-08-15 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2021-12-03 | Alliance Global Partners | Initiate | Buy |
| 2021-11-15 | Craig-Hallum | Initiate | Buy |